Logo

Pulmonary Arterial Hypertension Market Size, Share, Growth, and Regional Forecast, 2026 to 2033

Global Pulmonary Arterial Hypertension Market by Drug Class (Endothelin Receptor Antagonists, PDE-5 Inhibitors, Prostacyclin and Prostacyclin Analogs, and SGC Stimulators), by Type (Branded and Generics) by Route of Administration (Oral, Intravenous, and Inhalational), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Regional Analysis from 2026 to 2033

ID: PMRREP33199
Calendar

January 2026

250 Pages

Author : Abhijeet Surwase

Healthcare
  1. Executive Summary
    1. Global Pulmonary Arterial Hypertension Market Snapshot, 2026 and 2033
    2. Market Opportunity Assessment, 2026 – 2033, US$ Bn
    3. Key Market Trends
    4. Future Market Projections
    5. Premium Market Insights
    6. Industry Developments and Key Market Events
    7. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definition
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Key Trends
    3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
    4. COVID-19 Impact Analysis
    5. Forecast Factors – Relevance and Impact
  3. Value Added Insights
    1. Product Adoption Analysis
    2. Regulatory Landscape
    3. Value Chain Analysis
    4. Key Deals and Mergers
    5. PESTLE Analysis
    6. Porter’s Five Force Analysis
  4. Global Pulmonary Arterial Hypertension Market Outlook:
    1. Key Highlights
      1. Market Size (US$ Bn) and Y-o-Y Growth
      2. Absolute $ Opportunity
    2. Market Size (US$ Bn) Analysis and Forecast
      1. Historical Market Size (US$ Bn) Analysis, 2020-2025
      2. Market Size (US$ Bn) Analysis and Forecast, 2026–2033
    3. Global Pulmonary Arterial Hypertension Market Outlook: Drug Class
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Drug Class, 2020 – 2025
      3. Market Size (US$ Bn) Analysis  and Forecast, By Drug Class, 2026 – 2033
        1. Endothelin Receptor Antagonists
        2. PDE-5 Inhibitors
        3. Prostacyclin and Prostacyclin Analogs
        4. SGC Stimulators
      4. Market Attractiveness Analysis: By Drug Class
    4. Global Pulmonary Arterial Hypertension Market Outlook: Type
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Type, 2020 – 2025
      3. Market Size (US$ Bn) Analysis and Forecast, By Type, 2026 – 2033
        1. Branded
        2. Generics
      4. Market Attractiveness Analysis: Type
    5. Global Pulmonary Arterial Hypertension Market Outlook: Route of Administration
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Route of Administration, 2020 – 2025
      3. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2026 – 2033
        1. Oral
        2. Intravenous
        3. Inhalational
      4. Market Attractiveness Analysis: Route of Administration
    6. Global Pulmonary Arterial Hypertension Market Outlook: Distribution Channel
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Distribution Channel, 2020 – 2025
      3. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2026 – 2033
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
      4. Market Attractiveness Analysis: Distribution Channel
  5. Global Pulmonary Arterial Hypertension Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Region, 2020 – 2025
    3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2026 – 2033
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  6. North America Pulmonary Arterial Hypertension Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Drug Class
      3. By Type
      4. By Route of Administration
      5. By Distribution Channel
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. U.S.
      2. Canada
    4. Market Size (US$ Bn) Analysis   and Forecast, By Drug Class, 2026 – 2033
      1. Endothelin Receptor Antagonists
      2. PDE-5 Inhibitors
      3. Prostacyclin and Prostacyclin Analogs
      4. SGC Stimulators
    5. Market Size (US$ Bn) Analysis and Forecast, By Type, 2026 – 2033
      1. Branded
      2. Generics
    6. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2026 – 2033
      1. Oral
      2. Intravenous
      3. Inhalational
    7. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2026 – 2033
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    8. Market Attractiveness Analysis
  7. Europe Pulmonary Arterial Hypertension Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Drug Class
      3. By Type
      4. By Route of Administration
      5. By Distribution Channel
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Rest of Europe
    4. Market Size (US$ Bn) Analysis   and Forecast, By Drug Class, 2026 – 2033
      1. Endothelin Receptor Antagonists
      2. PDE-5 Inhibitors
      3. Prostacyclin and Prostacyclin Analogs
      4. SGC Stimulators
    5. Market Size (US$ Bn) Analysis and Forecast, By Type, 2026 – 2033
      1. Branded
      2. Generics
    6. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2026 – 2033
      1. Oral
      2. Intravenous
      3. Inhalational
    7. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2026 – 2033
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    8. Market Attractiveness Analysis
  8. East Asia Pulmonary Arterial Hypertension Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Drug Class
      3. By Type
      4. By Route of Administration
      5. By Distribution Channel
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. China
      2. Japan
      3. South Korea
    4. Market Size (US$ Bn) Analysis  and Forecast, By Drug Class, 2026 – 2033
      1. Endothelin Receptor Antagonists
      2. PDE-5 Inhibitors
      3. Prostacyclin and Prostacyclin Analogs
      4. SGC Stimulators
    5. Market Size (US$ Bn) Analysis and Forecast, By Type, 2026 – 2033
      1. Branded
      2. Generics
    6. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2026 – 2033
      1. Oral
      2. Intravenous
      3. Inhalational
    7. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2026 – 2033
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    8. Market Attractiveness Analysis
  9. South Asia & Oceania Pulmonary Arterial Hypertension Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Drug Class
      3. By Type
      4. By Route of Administration
      5. By Distribution Channel
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
    4. Market Size (US$ Bn) Analysis   and Forecast, By Drug Class, 2026 – 2033
      1. Endothelin Receptor Antagonists
      2. PDE-5 Inhibitors
      3. Prostacyclin and Prostacyclin Analogs
      4. SGC Stimulators
    5. Market Size (US$ Bn) Analysis and Forecast, By Type, 2026 – 2033
      1. Branded
      2. Generics
    6. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2026 – 2033
      1. Oral
      2. Intravenous
      3. Inhalational
    7. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2026 – 2033
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    8. Market Attractiveness Analysis
  10. Latin America Pulmonary Arterial Hypertension Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Drug Class
      3. By Type
      4. By Route of Administration
      5. By Distribution Channel
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    4. Market Size (US$ Bn) Analysis  and Forecast, By Drug Class, 2026 – 2033
      1. Endothelin Receptor Antagonists
      2. PDE-5 Inhibitors
      3. Prostacyclin and Prostacyclin Analogs
      4. SGC Stimulators
    5. Market Size (US$ Bn) Analysis and Forecast, By Type, 2026 – 2033
      1. Branded
      2. Generics
    6. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2026 – 2033
      1. Oral
      2. Intravenous
      3. Inhalational
    7. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2026 – 2033
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    8. Market Attractiveness Analysis
  11. Middle East & Africa Pulmonary Arterial Hypertension Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Drug Class
      3. By Type
      4. By Route of Administration
      5. By Distribution Channel
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. GCC Countries
      2. Egypt
      3. South Africa
      4. Northern Africa
      5. Rest of Middle East & Africa
    4. Market Size (US$ Bn) Analysis  and Forecast, By Drug Class, 2026 – 2033
      1. Endothelin Receptor Antagonists
      2. PDE-5 Inhibitors
      3. Prostacyclin and Prostacyclin Analogs
      4. SGC Stimulators
    5. Market Size (US$ Bn) Analysis and Forecast, By Type, 2026 – 2033
      1. Branded
      2. Generics
    6. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2026 – 2033
      1. Oral
      2. Intravenous
      3. Inhalational
    7. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2026 – 2033
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    8. Market Attractiveness Analysis
  12. Competition Landscape
    1. Market Structure
      1. Competition Intensity Mapping By Market
      2. Competition Dashboard
    2. Company Profiles (Details – Overview, Recent Developments)
      1. United Therapeutics Corporation
        1. Overview
        2. Segments and Drug Class & Distribution Channel
        3. Key Financials
        4. Market Developments
        5. Market Strategy
      2. Bayer AG
      3. Gilead Sciences, Inc.
      4. Merck & Co., Inc.
      5. Pfizer Inc.
      6. Johnson & Johnson
      7. Viatris Inc.
      8. GSK Plc.
      9. Sandoz Group AG
      10. Lupin Pharmaceuticals, Inc.
      11. Sun Pharmaceutical Industries Ltd
      12. Teva Pharmaceutical Industries Ltd
      13. Shubham Pharmachem Pvt Ltd
      14. Arena Pharmaceuticals
      15. Others
  13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations
Emailsales@persistencemarketresearch.com
UK

Corporate Office

Persistence Research & Consultancy Services Limited

Company Number : 15310893

Second Floor, 150 Fleet Street,London, EC4A 2DQ.

+44 203-837-5656
USA

Regional Office

Persistence Market Research

108 W 39th Street, Ste 1006,PMB2219, New York, NY 10018

+1 646-878-6329
India

Global Research centre

Persistence Market Research Private Limited

CIN : U74900PN2014PTC153163

IT Unit No. 504, 5th Floor, IconTower, Baner, Pune - 411045.

+91 906 779 3500SIN : +65 6531 3894 98
Quick Links
CareersTerms & ConditionsReturn PolicyMarket Research Report
Customer FAQ’sPrivacy PolicySitemap

Copyright © 2026 Persistence Market Research. All Rights Reserved

Connect With Us -